In the future, AI-assisted diagnostic tools could analyze your health status and prescribe personalized interventions tailored exactly to your biology

Kevin Schug discusses the ripple effects of the US government’s cost-cutting plans

The toughest peer review? A group of investors around a table, says Chad Mirkin, who talks commercialization lessons learned.

Nanotechnology pioneer Chad Mirkin talks eureka moments, the value of analytical science, and why curiosity comes first

If US laboratories will have less money to pay staff, conduct research, and collaborate American science will be greatly diminished

In terms of speed and robustness, mass spectrometry has inarguably made significant progress. But is the data we’re generating too much to handle?

Anne Marie Smith, Product Manager at ACD/Labs, discusses systems thinking, addressing unspoken challenges, and identifying the "empty fridge"

Reflecting on current trends in analytical science; Deirdre Cabooter discusses AI, personalized medicine and the resurgence of green chemistry

Ron Heeren discusses trends in spatial biology, the “resolution revolution”, and how interdisciplinary science must be supported policy